Biomaterials Market

Biomaterials Market Size, Growth by Type of Materials (Metallic, Ceramic, Polymers, Natural), Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurological disorders, Tissue Engineering, Ophthalmology) - Global Forecasts to 2025

Report Code: BT 1556 Jan, 2021, by marketsandmarkets.com

The global biomaterials market boasts a total value of $35.5 billion in 2020 and is projected to register a growth rate of 6.0% to reach a value of $47.5 billion by 2025. Market growth is driven mainly by factors such as the increased funds & grants by government bodies worldwide for the development of novel biomaterials, rising demand for medical implants, and the rising incidence of cardiovascular diseases, increasing research on regenerative medicine. In addition, high growth is expected for plastic surgery and wound healing applications, which will further drive the growth of the biomaterials market in the coming years.

Biomaterials Market

To know about the assumptions considered for the study, Request for Free Sample Report

Biomaterials Market Dynamics

Drivers: Growing demand for biomaterials in plastic surgery and wound healing applications

Plastic surgery and wound healing are prominent application areas for biomaterial-based products. In plastic surgery, biomaterials are widely used for implanting, rebuilding, repairing, and covering soft-tissue wounds, burns, or gaping holes in the human body naturally and safely. Innovations and technological advancements, coupled with the growing acceptance of aesthetic cosmetic procedures, would drive the demand for biomaterials in plastic surgery and wound healing applications in the coming years

Restraints: Stringent clinical & regulatory processes

Biomaterial-based medical devices are stringently regulated in several regions, including North America, Europe, and Asia, to ensure their quality and efficacy. This is primarily because most biomaterial-based medical devices are implantable. All new biomaterials require proof that they are safe and effective before they can be approved for marketing. In the US, the process for approval follows strict guidelines and regulations set by the FDA. According to the FDA, biomaterial-based products, such as implantable pacemakers, stents, and heart valves, are classified as Class III devices, which pose the highest potential risk of illness or injury. Thus, these devices are subjected to the premarket approval application pathway (the most stringent type of device marketing application).

Opportunities: Growing healthcare markets in emerging economies

The biomaterials market in emerging countries is expected to witness significant growth during the forecast period. This can majorly be attributed to the increasing patient population, rising adoption of implantable devices, growing awareness of CVDs, rising disposable income, improving healthcare infrastructure, and the presence of less-stringent regulatory guidelines (as compared to developed countries) in these countries.

Brazil, Russia, India, China, and South Africa (BRICS) are among the fastest-growing economies in the world. The World Economic Forum has estimated these emerging economies would account for one-third of the global healthcare expenditure by 2020. The growing demand for surgical procedures, rising geriatric population, and the increasing incidence of target diseases are some of the major factors that are expected to drive the demand for advanced healthcare services and novel medical devices in the respective healthcare systems of these countries. This is expected to offer potential growth opportunities to players operating in the biomaterials market in the coming years.

By type of material, the metallic biomaterials segment accounted for the largest share of the biomaterials market.

Based on type of material, the biomaterials market is segmented into Metallic Biomaterials, Polymeric Biomaterials, Ceramic Biomaterials, and Natural Biomaterials. Metallic Biomaterials dominated the market. The dominant share of this segment can primarily be attributed to the wide use of metals in the manufacturing of medical devices used in cardiovascular, dental, and orthopedic applications. The polymeric biomaterials segment, on the other hand, is expected to grow at the highest CAGR during the forecast period, mainly due to the increasing use of polymers in soft-tissue applications such as plastic surgeries.

By application, the cardiovascular segment accounted for the largest share of the biomaterials market.

Based on application, the biomaterials market is categorized into Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Tissue Engineering, Ophthalmology, Neurological/CNS, and Other Applications. The cardiovascular application segment dominated the market. The large share of the cardiovascular segment can be attributed to the increasing prevalence of cardiovascular diseases, rising geriatric population, increasing angiography procedures, and the growing adoption of cardiac stents, pacemakers, and implantable cardiac defibrillators.

Biomaterials Market by Region

North America accounted for the largest share of the biomaterials market.

North America accounted for the largest share of the biomaterials market, followed by Europe. The large share of the North American regional segment can be attributed to the increase in biomaterial-based research, rising demand for plastic surgeries, growing incidence of cancer, and the rising prevalence of cardiovascular diseases.

Biomaterials Market Key Players

Key players in this market includes BASF SE (Germany), Covestro AG (Germany), Celanese Corporation (US), Corbion (Netherlands), Royal DSM (Netherlands), Evonik Industries (Germany), Carpenter Technology Corporation (US), Berkeley Advanced Biomaterials (US), Cam Bioceramics B.V. (Netherlands), CoorsTek Inc. (US), CeramTec (Germany), and Gelita AG (Germany).

Biomaterials Market Scope

Report Metrics

Details

Market Size value 2025

USD 47.5 billion

Growth Rate

6.0% CAGR

Largest Market

North America

Market Dynamics

Drivers, Opportunities, Restraints & Challenges

Largest Share Segments

the metallic biomaterials, the cardiovascular

Forecasts up to

2025

Market Segmentation

Type of materials, Application and Region

Biomaterials Market Growth Drivers

  • Increased funds and grants by government bodies and universities for the development of novel biomaterials
  • Increasing demand for implantable devices
  • Growing demand for biomaterials in plastic surgery and wound healing applications
  • Rising incidence of cardiovascular diseases
  • Increasing research on regenerative medicine

Biomaterials Market Growth Opportunities

  • Growing healthcare market in emerging economies
  • Increasing number of free-trade agreements

Geographies covered

North America, Europe, Asia, MEA and the Rest of the World

This report categorizes the global biomaterials market into the following segments and subsegments:

By Type

  • Metallic Biomaterials
    • Stainless Steel
    • Titanium & Titanium Alloys
    • Cobalt-Chrome Alloys
    • Gold
    • Silver
    • Magnesium
  • Polymeric Biomaterials
    • Polymethylmethacrylate
    • Polyethylene
    • Polyester
    • Silicone Rubber
    • Nylon
    • Polyetheretherketone
    • Other Polymeric Biomaterials
  • Ceramics
    • Calcium Phosphate
    • Zirconia
    • Aluminum Oxide
    • Calcium Sulfate
    • Carbon
    • Glass
  • Natural Biomaterials
    • Hyaluronic Acid
    • Collagen
    • Gelatin
    • Fibrin
    • Cellulose
    • Chitin
    • Alginates
    • Silk

By Application

  • Cardiovascular
    • Catheters
    • Stents
    • Implantable Cardiac Defibrillators
    • Pacemakers
    • Sensors
    • Heart Valves
    • Vascular Grafts
    • Guidewires
    • Others
  • Orthopedic
    • Joint Replacement
      • Knee Replacement
      • Hip Replacement
      • Shoulder Replacement
      • Others
    • Viscosupplementation
    • Bioresorbable Tissue Fixation
      • Suture Anchors
      • Interference Screws
      • Meniscal Repair Tacks
      • Meshes
    • Spine
      • Spinal Fusion Surgeries
      • Minimally Invasive Fusion Surgeries
      • Motion Preservation & Dynamic Stabilization Surgeries
        • Pedicle-Based Rod Systems
        • Interspinous Spacers
        • Artificial Discs
    • Fracture Fixation Devices
      • Bone Plates
      • Screws
      • Pins
      • Rods
      • Wires
    • Synthetics Bone Grafts
  • Ophthalmology
    • Contact Lenses
      • Intraocular Lenses
      • Functional Replacement of Ocular Tissues
      • Synthetic Corneas
      • Others
  • Dental
    • Dental Implants
    • Dental Bone Grafts & Substitutes
    • Dental Membranes
    • Tissue Regeneration
  • Plastic Surgery
    • Soft-Tissue Fillers
    • Craniofacial Surgery
  • Wound Healing
    • Wound Closure Devices
      • Sutures
      • Staples
    • Surgical Hemostats
    • Internal Tissue Sealants
    • Adhesion Barriers
    • Hernia Meshes
  • Tissue Engineering
    • Scaffolds for Regenerative Medicine
    • Biosensing
    • Tailoring of Inorganic Nanoparticles
  • Neurological/Central Nervous System Applications
    • Shunting Systems
    • Cortical Neural Prosthetics
    • Hydrogel Scaffolds for CNS Repair
    • Neural Stem Cell Encapsulation
  • Other Applications
    • Drug Delivery Systems
    • Gastrointestinal Applications
    • Bariatric Surgery
    • Urinary Applications

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe (RoE)
  • Asia Pacific (APAC)
    • Japan
    • China
    • India
    • Rest of Asia Pacific (RoAPAC)
  • Rest of the World (RoW)

Recent Developments:

  • In 2019, Royal DSM (Netherlands) and ProMed Pharma (US) partnered for the development of novel sustained release drug delivery solutions in the polymeric drug delivery area.
  • In 2018, Covestro AG (Germany) signed an MoU with a group of ten companies and two research organizations with an aim to build a Composite Application Center (CAC) in Singapore. This was aimed to develop end-to-end solutions for advanced composites, such as thermoplastic materials.
  • In 2019, Celanese Corporation (US) announced an expansion of its production facility of thermoplastic co-polyesters. This expansion is expected to support the demand of its global engineered

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 31)
    1.1 OBJECTIVES OF STUDY
    1.2 MARKET DEFINITION
           1.2.1 INCLUSIONS AND EXCLUSIONS
    1.3 MARKET SCOPE
           1.3.1 MARKETS COVERED
                    FIGURE 1 GLOBAL BIOMATERIALS MARKET SEGMENTATION
           1.3.2 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 35)
    2.1 RESEARCH DATA
           FIGURE 2 RESEARCH DESIGN
           2.1.1 SECONDARY DATA
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY DATA
                    FIGURE 3 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
                               FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS
    2.2 MARKET SIZE ESTIMATION
           FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
           FIGURE 6 MARKET SIZE ESTIMATION: GLOBAL MARKET
           FIGURE 7 SEGMENTAL ASSESSMENT: MARKET
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
           FIGURE 8 DATA TRIANGULATION METHODOLOGY
    2.4 MARKET SHARE ESTIMATION
    2.5 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY (Page No. - 44)
    FIGURE 9 BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025
    FIGURE 10 METALLIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025
    FIGURE 11 CERAMIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025
    FIGURE 12 POLYMERIC BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025
    FIGURE 13 NATURAL BIOMATERIALS MARKET, BY TYPE, 2020 VS. 2025
    FIGURE 14 CARDIOVASCULAR APPLICATIONS DOMINATED THE GLOBAL MARKET IN 2019
    FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE GLOBAL MARKET

4 PREMIUM INSIGHTS (Page No. - 50)
    4.1 BIOMATERIALS MARKET OVERVIEW
           FIGURE 16 INCREASING DEMAND FOR IMPLANTABLE DEVICES TO DRIVE THE GROWTH OF THE MARKET
    4.2 NORTH AMERICA: MARKET, BY TYPE & COUNTRY (2019)
           FIGURE 17 METALLIC BIOMATERIALS TO DOMINATE THE NORTH AMERICAN MARKET IN 2019
    4.3 METALLIC BIOMATERIALS MARKET, BY TYPE
           FIGURE 18 TITANIUM & TITANIUM ALLOYS ARE PROJECTED TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD

5 MARKET OVERVIEW (Page No. - 53)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           FIGURE 19 GLOBAL MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, CHALLENGES, AND TRENDS
           5.2.1 DRIVERS
                    5.2.1.1 Increased funds and grants by government bodies and universities for the development of novel biomaterials
                    5.2.1.2 Increasing demand for implantable devices
                    5.2.1.3 Growing demand for biomaterials in plastic surgery and wound healing applications
                    5.2.1.4 Rising incidence of cardiovascular diseases
                    5.2.1.5 Increasing research on regenerative medicine
           5.2.2 RESTRAINTS
                    5.2.2.1 Stringent clinical & regulatory processes
                    5.2.2.2 Unfavorable healthcare reforms in the US
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Growing healthcare market in emerging economies
                    5.2.3.2 Increasing number of free-trade agreements
           5.2.4 CHALLENGES
                    5.2.4.1 Limitations of biomaterial-based products
                    5.2.4.2 Shortage of skilled surgeons
           5.2.5 TRENDS
                    5.2.5.1 Impact of COVID-19 on the global market

6 REGULATORY ASSESSMENT (Page No. - 61)
    6.1 INTRODUCTION
    6.2 US
           6.2.1 INTRODUCTION
           6.2.2 FDA DEVICE CLASSIFICATION
                    FIGURE 20 US: REGULATORY APPROVAL PROCESS
           6.2.3 US: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 21 REGULATORY APPROVAL TIMELINE IN THE US
           6.2.4 STRINGENT FDA REGULATIONS GOVERNING PRODUCT APPROVALS
    6.3 CANADA
           6.3.1 INTRODUCTION
                    FIGURE 22 CANADA: REGULATORY APPROVAL PROCESS
           6.3.2 CANADA: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 23 REGULATORY APPROVAL TIMELINE IN CANADA
           6.3.3 HEALTH CANADA CLASSIFICATION
    6.4 EUROPE
           6.4.1 INTRODUCTION
           6.4.2 EUROPEAN MEDICAL DEVICE CLASSIFICATION
                    FIGURE 24 EUROPE: REGULATORY APPROVAL PROCESS
           6.4.3 EUROPE: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 25 REGULATORY APPROVAL TIMELINE IN EUROPE
           6.4.4 EUROPEAN REGULATORY PROCESS TO GET MORE STRINGENT IN FUTURE
    6.5 JAPAN
           6.5.1 INTRODUCTION
           6.5.2 PMDA DEVICE CLASSIFICATION
                    FIGURE 26 JAPAN: REGULATORY APPROVAL PROCESS
           6.5.3 JAPAN: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 27 REGULATORY APPROVAL TIMELINE IN JAPAN
           6.5.4 REVISION OF THE PHARMACEUTICAL AFFAIRS LAW (PAL) AND IMPLEMENTATION OF THE NEW PMD ACT IN JAPAN
    6.6 CHINA
           6.6.1 INTRODUCTION
           6.6.2 CFDA DEVICE CLASSIFICATION
                    FIGURE 28 CHINA: REGULATORY APPROVAL PROCESS
           6.6.3 CHINA: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 29 REGULATORY APPROVAL TIMELINE IN CHINA
           6.6.4 RISING HURDLES IN THE REGULATORY PROCESS IN CHINA
    6.7 INDIA
           6.7.1 INTRODUCTION
                    FIGURE 30 INDIA: REGULATORY APPROVAL PROCESS
           6.7.2 INDIAN MEDICAL DEVICES CLASSIFICATION
    6.8 AUSTRALIA
           6.8.1 INTRODUCTION
           6.8.2 TGA DEVICE CLASSIFICATION
                    FIGURE 31 AUSTRALIA: REGULATORY APPROVAL PROCESS
           6.8.3 AUSTRALIA: REGULATORY APPROVAL TIMELINE ASSESSMENT
                    FIGURE 32 REGULATORY APPROVAL TIMELINE IN AUSTRALIA

7 BIOMATERIALS MARKET, BY TYPE (Page No. - 82)
    7.1 INTRODUCTION
           TABLE 1 IMPORTANT PROPERTIES OF BIOMATERIALS, BY APPLICATION
           TABLE 2 GLOBAL MARKET, BY TYPE, 2016–2019
           TABLE 3 GLOBAL MARKET, BY TYPE, 2020–2025
    7.2 METALLIC BIOMATERIALS
           TABLE 4 METALLIC MARKET, BY TYPE, 2016–2019
           TABLE 5 METALLIC MARKET, BY TYPE, 2020–2025
           TABLE 6 METALLIC MARKET, BY REGION, 2016–2019
           TABLE 7 METALLIC MARKET, BY REGION, 2020–2025
           7.2.1 STAINLESS STEEL
                    7.2.1.1 Stainless steel dominates the metallic biomaterials market
                               TABLE 8 STAINLESS STEEL MARKET, BY REGION, 2016–2019
                               TABLE 9 STAINLESS STEEL MARKET, BY REGION, 2020–2025
           7.2.2 TITANIUM & TITANIUM ALLOYS
                    7.2.2.1 Growing number of joint replacement procedures will drive the market for titanium biomaterials
                               TABLE 10 TITANIUM & TITANIUM ALLOY MARKET, BY REGION, 2016–2019
                               TABLE 11 TITANIUM & TITANIUM ALLOY MARKET, BY REGION, 2020–2025
           7.2.3 COBALT-CHROME ALLOYS
                    7.2.3.1 Low cost and excellent corrosion resistance have driven the use of cobalt-chrome alloys
                               TABLE 12 COBALT-CHROME ALLOY MARKET, BY REGION, 2016–2019
                               TABLE 13 COBALT-CHROME ALLOY MARKET, BY REGION, 2020–2025
           7.2.4 GOLD
                    7.2.4.1 Expanding applications of gold nanoparticles to drive the demand for gold biomaterials
                               TABLE 14 GOLD MARKET, BY REGION, 2016–2019
                               TABLE 15 GOLD MARKET, BY REGION, 2020–2025
           7.2.5 SILVER
                    7.2.5.1 Toxic properties and low aesthetic appeal likely to limit the use of silver in biomaterial-based products
                               TABLE 16 SILVER BIOMATERIALS MARKET, BY REGION, 2016–2019
                               TABLE 17 SILVER MARKET, BY REGION, 2020–2025
           7.2.6 MAGNESIUM
                    7.2.6.1 Biodegradable characteristic of magnesium stimulates the growth of this market segment
                               TABLE 18 MAGNESIUM MARKET, BY REGION, 2016–2019
                               TABLE 19 MAGNESIUM MARKET, BY REGION, 2020–2025
    7.3 POLYMERIC BIOMATERIALS
           TABLE 20 APPLICATIONS OF SYNTHETIC POLYMERS
           TABLE 21 POLYMERIC MARKET, BY TYPE, 2016–2019
           TABLE 22 POLYMERIC MARKET, BY TYPE, 2020–2025
           TABLE 23 POLYMERIC MARKET, BY REGION, 2016–2019
           TABLE 24 POLYMERIC MARKET, BY REGION, 2020–2025
           7.3.1 POLYMETHYLMETHACRYLATE (PMMA)
                    7.3.1.1 PMMA dominates the polymeric biomaterials market
                               TABLE 25 POLYMETHYLMETHACRYLATE MARKET, BY REGION, 2016–2019
                               TABLE 26 POLYMETHYLMETHACRYLATE MARKET, BY REGION, 2020–2025
           7.3.2 POLYETHYLENE
                    7.3.2.1 Wear and tear resistance of polyethylene has made it popular in hip and knee joint replacements
                               TABLE 27 POLYETHYLENE MARKET, BY REGION, 2016–2019
                               TABLE 28 POLYETHYLENE MARKET, BY REGION, 2020–2025
           7.3.3 POLYESTER
                    7.3.3.1 Biodegradable nature and biocompatibility of polyester will drive its use in various medical applications
                               TABLE 29 POLYESTER MARKET, BY REGION, 2016–2019
                               TABLE 30 POLYESTER MARKET, BY REGION, 2020–2025
           7.3.4 POLYVINYLCHLORIDE
                    7.3.4.1 Heavy chlorine content of PVC is likely to hamper the market growth
                               TABLE 31 POLYVINYLCHLORIDE MARKET, BY REGION, 2016–2019
                               TABLE 32 POLYVINYLCHLORIDE MARKET, BY REGION, 2020–2025
           7.3.5 SILICONE RUBBER
                    7.3.5.1 Silicone rubbers are non-reactive, stable, and resistant to extreme environments and temperatures
                               TABLE 33 SILICONE RUBBER MARKET, BY REGION, 2016–2019
                               TABLE 34 SILICONE RUBBER MARKET, BY REGION, 2020–2025
           7.3.6 NYLON
                    7.3.6.1 Low weight, corrosion resistance, and wide applications of nylon are expected to drive the market demand
                               TABLE 35 NYLON BIOMATERIALS MARKET, BY REGION, 2016–2019
                               TABLE 36 NYLON MARKET, BY REGION, 2020–2025
           7.3.7 POLYETHERETHERKETONE
                    7.3.7.1 PEEK is gaining popularity as a viable alternative to metals
                               TABLE 37 POLYETHERETHERKETONE MARKET, BY REGION, 2016–2019
                               TABLE 38 POLYETHERETHERKETONE MARKET, BY REGION, 2020–2025
           7.3.8 OTHER POLYMERIC BIOMATERIALS
                    TABLE 39 OTHER POLYMERIC MARKET, BY REGION, 2016–2019
                    TABLE 40 OTHER POLYMERIC MARKET, BY REGION, 2020–2025
    7.4 CERAMIC BIOMATERIALS
           TABLE 41 CERAMIC MARKET, BY TYPE, 2016–2019
           TABLE 42 CERAMIC MARKET, BY TYPE, 2020–2025
           TABLE 43 CERAMIC MARKET, BY REGION, 2016–2019
           TABLE 44 CERAMIC MARKET, BY REGION, 2020–2025
           7.4.1 CALCIUM PHOSPHATE
                    7.4.1.1 Calcium phosphate is the largest segment in the ceramic biomaterials market
                               TABLE 45 CALCIUM PHOSPHATE MARKET, BY REGION, 2016–2019
                               TABLE 46 CALCIUM PHOSPHATE MARKET, BY REGION, 2020–2025
           7.4.2 ZIRCONIA
                    7.4.2.1 Bio-inertness and low wear rate of zirconia will boost the market growth
                               TABLE 47 ZIRCONIA MARKET, BY REGION, 2016–2019
                               TABLE 48 ZIRCONIA MARKET, BY REGION, 2020–2025
           7.4.3 ALUMINUM OXIDE
                    7.4.3.1 Increasing use of aluminum oxide in hip replacements and dental implants to drive the market
                               TABLE 49 ALUMINUM OXIDE MARKET, BY REGION, 2016–2019
                               TABLE 50 ALUMINUM OXIDE MARKET, BY REGION, 2020–2025
           7.4.4 CALCIUM SULFATE
                    7.4.4.1 Fast resorption rate of calcium sulfate is likely to hamper its use
                               TABLE 51 CALCIUM SULFATE MARKET, BY REGION, 2016–2019
                               TABLE 52 CALCIUM SULFATE MARKET, BY REGION, 2020–2025
           7.4.5 CARBON
                    7.4.5.1 Increasing use of carbon nanofibers in regenerative medicine and cancer treatment will drive market growth
                               TABLE 53 CARBON MARKET, BY REGION, 2016–2019
                               TABLE 54 CARBON MARKET, BY REGION, 2020–2025
           7.4.6 GLASS
                    7.4.6.1 Rising number of orthopedic and dental procedures is likely to drive the demand for glass biomaterials
                               TABLE 55 GLASS MARKET, BY REGION, 2016–2019
                               TABLE 56 GLASS MARKET, BY REGION, 2020–2025
    7.5 NATURAL BIOMATERIALS
           TABLE 57 APPLICATIONS OF NATURAL BIOMATERIALS
           TABLE 58 NATURAL BIOMATERIALS MARKET, BY TYPE, 2016–2019
           TABLE 59 NATURAL MARKET, BY TYPE, 2020–2025
           TABLE 60 NATURAL MARKET, BY REGION, 2016–2019
           TABLE 61 NATURAL MARKET, BY REGION, 2020–2025
           7.5.1 HYALURONIC ACID
                    7.5.1.1 Rising prevalence of osteoarthritis to drive the hyaluronic acid market
                               TABLE 62 HYALURONIC ACID MARKET, BY REGION, 2016–2019
                               TABLE 63 HYALURONIC ACID MARKET, BY REGION, 2020–2025
           7.5.2 COLLAGEN
                    7.5.2.1 Rising prevalence of target applications to drive growth in the collagen market
                               TABLE 64 COLLAGEN MARKET, BY REGION, 2016–2019
                               TABLE 65 COLLAGEN MARKET, BY REGION, 2020–2025
           7.5.3 GELATIN
                    7.5.3.1 Low cost of gelatin to drive its market growth
                               TABLE 66 GELATIN MARKET, BY REGION, 2016–2019
                               TABLE 67 GELATIN MARKET, BY REGION, 2020–2025
           7.5.4 FIBRIN
                    7.5.4.1 Fibrin biomaterials were among the first used to prevent bleeding
                               TABLE 68 FIBRIN MARKET, BY REGION, 2016–2019
                               TABLE 69 FIBRIN MARKET, BY REGION, 2020–2025
           7.5.5 CELLULOSE
                    7.5.5.1 Cellulose finds applications in wound healing, skin regeneration, and ophthalmology
                               TABLE 70 CELLULOSE MARKET, BY REGION, 2016–2019
                               TABLE 71 CELLULOSE MARKET, BY REGION, 2020–2025
           7.5.6 CHITIN
                    7.5.6.1 Chitin accelerates skin regeneration and possesses high biocompatibility
                               TABLE 72 CHITIN MARKET, BY REGION, 2016–2019
                               TABLE 73 CHITIN MARKET, BY REGION, 2020–2025
           7.5.7 ALGINATES
                    7.5.7.1 Various applications of alginates include wound healing, tissue engineering & regenerative medicine, and drug delivery
                               TABLE 74 ALGINATE MARKET, BY REGION, 2016–2019
                               TABLE 75 ALGINATE MARKET, BY REGION, 2020–2025
           7.5.8 SILK
                    7.5.8.1 Flexibility, glossiness, and adhesive abilities of silk have made it popular in cosmetic applications
                               TABLE 76 SILK MARKET, BY REGION, 2016–2019
                               TABLE 77 SILK MARKET, BY REGION, 2020–2025

8 BIOMATERIALS MARKET, BY APPLICATION (Page No. - 119)
    8.1 INTRODUCTION
           TABLE 78 GLOBAL MARKET, BY APPLICATION, 2016–2019
           TABLE 79 MARKET, BY APPLICATION, 2020–2025
    8.2 CARDIOVASCULAR
           TABLE 80 MARKET FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2016–2019
           TABLE 81 MARKET FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2020–2025
           TABLE 82 MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2016–2019
           TABLE 83 MARKET FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2020–2025
           8.2.1 CATHETERS
                    8.2.1.1 Shift in patient preference from traditional open surgeries to minimally invasive surgeries to drive the catheters market
                               TABLE 84 MARKET FOR CATHETERS, BY REGION, 2016–2019
                               TABLE 85 MARKET FOR CATHETERS, BY REGION, 2020–2025
           8.2.2 STENTS
                    8.2.2.1 Increasing number of coronary intervention procedures to boost the demand for implantable stents
                               TABLE 86 MARKET FOR STENTS, BY REGION, 2016–2019
                               TABLE 87 MARKET FOR STENTS, BY REGION, 2020–2025
           8.2.3 IMPLANTABLE CARDIAC DEFIBRILLATORS
                    8.2.3.1 Growing geriatric population is expected to increase the demand for implantable cardiac defibrillators
                               TABLE 88 MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2016–2019
                               TABLE 89 MARKET FOR IMPLANTABLE CARDIAC DEFIBRILLATORS, BY REGION, 2020–2025
           8.2.4 PACEMAKERS
                    8.2.4.1 High prevalence of bradycardia is increasing the demand for pacemakers
                               TABLE 90 GLOBAL MARKET FOR PACEMAKERS, BY REGION, 2016–2019
                               TABLE 91 MARKET FOR PACEMAKERS, BY REGION, 2020–2025
           8.2.5 SENSORS
                    8.2.5.1 Increasing prevalence of cardiac disorders is boosting the demand for cardiovascular sensors
                               TABLE 92 MARKET FOR SENSORS, BY REGION, 2016–2019
                               TABLE 93 MARKET FOR SENSORS, BY REGION, 2020–2025
           8.2.6 HEART VALVES
                    8.2.6.1 Growing geriatric population is set to increase the demand for prosthetic valves
                               TABLE 94 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS
                               TABLE 95 MARKET FOR HEART VALVES, BY REGION, 2016–2019
                               TABLE 96 MARKET FOR HEART VALVES, BY REGION, 2020–2025
           8.2.7 VASCULAR GRAFTS
                    8.2.7.1 Various research studies related to the use of biomaterials in vascular grafts will open opportunities for growth of the market
                               TABLE 97 GLOBAL MARKET FOR VASCULAR GRAFTS, BY REGION, 2016–2019
                               TABLE 98 MARKET FOR VASCULAR GRAFTS, BY REGION, 2020–2025
           8.2.8 GUIDEWIRES
                    8.2.8.1 Guidewires are widely used for guiding catheters and placing stents inside the heart
                               TABLE 99 MARKET FOR GUIDEWIRES, BY REGION, 2016–2019
                               TABLE 100 MARKET FOR GUIDEWIRES, BY REGION, 2020–2025
           8.2.9 OTHER PRODUCTS
                    TABLE 101 MARKET FOR OTHER PRODUCTS, BY REGION, 2016–2019
                    TABLE 102 MARKET FOR OTHER PRODUCTS, BY REGION, 2020–2025
    8.3 ORTHOPEDIC
           TABLE 103 BIOMATERIALS MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2016–2019
           TABLE 104 MARKET FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2020–2025
           TABLE 105 MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2016–2019
           TABLE 106 MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2020–2025
           8.3.1 JOINT REPLACEMENT
                    TABLE 107 JOINT REPLACEMENT MARKET, BY TYPE, 2016–2019
                    TABLE 108 JOINT REPLACEMENT MARKET, BY TYPE, 2020–2025
                    TABLE 109 JOINT REPLACEMENT MARKET, BY REGION, 2016–2019
                    TABLE 110 JOINT REPLACEMENT MARKET, BY REGION, 2020–2025
                    8.3.1.1 Knee replacement
                               8.3.1.1.1 Increasing number of knee replacement procedures across the globe to drive market growth
                                             TABLE 111 KNEE REPLACEMENT MARKET, BY REGION, 2016–2019
                                             TABLE 112 KNEE REPLACEMENT MARKET, BY REGION, 2020–2025
                    8.3.1.2 Hip replacement
                               8.3.1.2.1 Hip and knee joint replacements are the most commonly performed procedures in the US—a key factor driving growth
                                             TABLE 113 HIP REPLACEMENT MARKET, BY REGION, 2016–2019
                                             TABLE 114 HIP REPLACEMENT MARKET, BY REGION, 2020–2025
                    8.3.1.3 Shoulder replacement
                               8.3.1.3.1 Shoulder replacement is the most common joint replacement surgery conducted globally
                                             TABLE 115 SHOULDER REPLACEMENT BIOMATERIALS MARKET, BY REGION, 2016–2019
                                             TABLE 116 SHOULDER REPLACEMENT MARKET, BY REGION, 2020–2025
                    8.3.1.4 Other joint replacement applications
                               TABLE 117 OTHER JOINT REPLACEMENT MARKET, BY REGION, 2016–2019
                               TABLE 118 OTHER JOINT REPLACEMENT MARKET, BY REGION, 2020–2025
           8.3.2 VISCOSUPPLEMENTATION
                    8.3.2.1 Rising cases of osteoarthritis will drive growth in the viscosupplementation market
                               TABLE 119 VISCOSUPPLEMENTATION MARKET, BY REGION, 2016–2019
                               TABLE 120 VISCOSUPPLEMENTATION MARKET, BY REGION, 2020–2025
           8.3.3 BIORESORBABLE TISSUE FIXATION
                    TABLE 121 BIORESORBABLE BIOMATERIALS MARKET, BY PRODUCT, 2016–2019
                    TABLE 122 BIORESORBABLE MARKET, BY PRODUCT, 2020–2025
                    TABLE 123 BIORESORBABLE MARKET, BY REGION, 2016–2019
                    TABLE 124 BIORESORBABLE MARKET, BY REGION, 2020–2025
                    8.3.3.1 Suture anchors
                               8.3.3.1.1 Growing awareness about suture anchor devices will drive market growth
                                             TABLE 125 GLOBAL MARKET FOR SUTURE ANCHORS, BY REGION, 2016–2019
                                             TABLE 126 MARKET FOR SUTURE ANCHORS, BY REGION, 2020–2025
                    8.3.3.2 Interference screws
                               8.3.3.2.1 Increasing awareness about ACL will contribute to market growth
                                             TABLE 127 MARKET FOR INTERFERENCE SCREWS, BY REGION, 2016–2019
                                             TABLE 128 MARKET FOR INTERFERENCE SCREWS, BY REGION, 2020–2025
                    8.3.3.3 Meniscal repair tacks
                               8.3.3.3.1 Rising sports injuries will drive growth in the meniscal repair tacks market
                                             TABLE 129 MARKET FOR MENISCAL REPAIR TACKS, BY REGION, 2016–2019
                                             TABLE 130 MARKET FOR MENISCAL REPAIR TACKS, BY REGION, 2020–2025
                    8.3.3.4 Meshes
                               8.3.3.4.1 Wear resistance, proper shaping, and holding capacity of bioresorbable implants increase the demand for bioresorbable meshes
                                             TABLE 131 GLOBAL MARKET FOR MESHES, BY REGION, 2016–2019
                                             TABLE 132 MARKET FOR MESHES, BY REGION, 2020–2025
           8.3.4 SPINE
                    TABLE 133 MARKET FOR SPINE SURGERIES, BY TYPE, 2016–2019
                    TABLE 134 MARKET FOR SPINE SURGERIES, BY TYPE, 2020–2025
                    TABLE 135 MARKET FOR SPINE SURGERIES, BY REGION, 2016–2019
                    TABLE 136 MARKET FOR SPINE SURGERIES, BY REGION, 2020–2025
                    8.3.4.1 Spinal fusion
                               8.3.4.1.1 Introduction of minimally invasive spinal fusion procedures and better clinical outcomes to drive market growth
                                             TABLE 137 GLOBAL MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2016–2019
                                             TABLE 138 MARKET FOR SPINAL FUSION SURGERIES, BY REGION, 2020–2025
                    8.3.4.2 Minimally invasive fusion
                               8.3.4.2.1 Advantages such as lesser pain post surgery and faster recovery to drive the demand for minimally invasive fusion procedures
                                             TABLE 139 MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES, BY REGION, 2016–2019
                                             TABLE 140 MARKET FOR MINIMALLY INVASIVE FUSION SURGERIES, BY REGION, 2020–2025
                    8.3.4.3 Motion preservation & dynamic stabilization
                                             TABLE 141 MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2016–2019
                                             TABLE 142 MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY PRODUCT, 2020–2025
                                             TABLE 143 BIOMATERIALS MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2016–2019
                                             TABLE 144 MARKET FOR MOTION PRESERVATION & DYNAMIC STABILIZATION SURGERIES, BY REGION, 2020–2025
                               8.3.4.3.1 Pedicle-based rod systems
                                             8.3.4.3.1.1 Rising geriatric population will result in growth in the pedicle-based rod systems market
                                             TABLE 145 MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2016–2019
                                             TABLE 146 MARKET FOR PEDICLE-BASED ROD SYSTEMS, BY REGION, 2020–2025
                               8.3.4.3.2 Interspinous spacers
                                             8.3.4.3.2.1 High prevalence of degenerative spinal conditions will contribute to the growth of the interspinous spacers market
                                             TABLE 147 MARKET FOR INTERSPINOUS SPACERS, BY REGION, 2016–2019
                                             TABLE 148 MARKET FOR INTERSPINOUS SPACERS, BY REGION, 2020–2025
                               8.3.4.3.3 Artificial discs
                                             8.3.4.3.3.1 High biocompatibility of biomaterials has led to their increased use in artificial discs
                                             TABLE 149 GLOBAL MARKET FOR ARTIFICIAL DISCS, BY REGION, 2016–2019
                                             TABLE 150 MARKET FOR ARTIFICIAL DISCS, BY REGION, 2020–2025
           8.3.5 FRACTURE FIXATION DEVICES
                    TABLE 151 MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE, 2016–2019
                    TABLE 152 MARKET FOR FRACTURE FIXATION DEVICES, BY TYPE, 2020–2025
                    TABLE 153 MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2016–2019
                    TABLE 154 MARKET FOR FRACTURE FIXATION DEVICES, BY REGION, 2020–2025
                    8.3.5.1 Bone plates
                               8.3.5.1.1 Biomaterials form an integral component of bone plates due to their high biocompatibility
                                             TABLE 155 GLOBAL MARKET FOR BONE PLATES, BY REGION, 2016–2019
                                             TABLE 156 MARKET FOR BONE PLATES, BY REGION, 2020–2025
                    8.3.5.2 Screws
                               8.3.5.2.1 Screws made up of biomaterials such as stainless steel, titanium, and cobalt are extensively used in orthopedic procedures
                                             TABLE 157 MARKET FOR SCREWS, BY REGION, 2016–2019
                                             TABLE 158 MARKET FOR SCREWS, BY REGION, 2020–2025
                    8.3.5.3 Pins
                               8.3.5.3.1 Nonreactive metallic biomaterials such as stainless steel, titanium, and cobalt are majorly used to manufacture pins
                                             TABLE 159 MARKET FOR PINS, BY REGION, 2016–2019
                                             TABLE 160 MARKET FOR PINS, BY REGION, 2020–2025
                    8.3.5.4 Rods
                               8.3.5.4.1 Rods are preferred for fracture fixation procedures due to their high rigidity, easy mobility, and cost efficiency
                                             TABLE 161 GLOBAL MARKET FOR RODS, BY REGION, 2016–2019
                                             TABLE 162 MARKET FOR RODS, BY REGION, 2020–2025
                    8.3.5.5 Wires
                               8.3.5.5.1 Wires made up of metallic biomaterials are widely used to treat fractures of small bones
                                             TABLE 163 MARKET FOR WIRES, BY REGION, 2016–2019
                                             TABLE 164 MARKET FOR WIRES, BY REGION, 2020–2025
           8.3.6 SYNTHETICS BONE GRAFTS
                    8.3.6.1 Growing geriatric population and increasing incidence of sports-related injuries are driving the market for synthetic bone grafts
                               TABLE 165 MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2016–2019
                               TABLE 166 MARKET FOR SYNTHETIC BONE GRAFTS, BY REGION, 2020–2025
    8.4 OPHTHALMOLOGY
           TABLE 167 GLOBAL MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2016–2019
           TABLE 168 MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY TYPE, 2020–2025
           TABLE 169 MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2016–2019
           TABLE 170 GLOBAL MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2020–2025
           8.4.1 CONTACT LENSES
                    8.4.1.1 High cases of refractive errors and preference for contact lenses over spectacles to drive the market for contact lenses
                               TABLE 171 MARKET FOR CONTACT LENSES, BY REGION, 2016–2019
                               TABLE 172 MARKET FOR CONTACT LENSES, BY REGION, 2020–2025
           8.4.2 INTRAOCULAR LENSES
                    8.4.2.1 Increasing prevalence of cataracts to drive the number of cataract surgeries performed
                               TABLE 173 BIOMATERIALS MARKET FOR INTRAOCULAR LENSES, BY REGION, 2016–2019
                               TABLE 174 MARKET FOR INTRAOCULAR LENSES, BY REGION, 2020–2025
           8.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES
                    8.4.3.1 Increasing funding and research activities for developing bionic eyes are driving the market for this application
                               TABLE 175 MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2016–2019
                               TABLE 176 GLOBAL MARKET FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2020–2025
           8.4.4 SYNTHETIC CORNEAS
                    8.4.4.1 Growing number of corneal blindness cases worldwide to boost the demand for synthetic collagen biomaterials
                               TABLE 177 MARKET FOR SYNTHETIC CORNEAS, BY REGION, 2016–2019
                               TABLE 178 MARKET FOR SYNTHETIC CORNEAS, BY REGION, 2020–2025
           8.4.5 OTHER OPHTHALMOLOGY APPLICATIONS
                    TABLE 179 GLOBAL MARKET FOR OTHER OPHTHALMOLOGY APPLICATIONS, BY REGION, 2016–2019
                    TABLE 180 MARKET FOR OTHER OPHTHALMOLOGY APPLICATIONS, BY REGION, 2020–2025
    8.5 DENTAL
           TABLE 181 MARKET FOR DENTAL APPLICATIONS, BY PRODUCT, 2016–2019
           TABLE 182 GLOBAL MARKET FOR DENTAL APPLICATIONS, BY PRODUCT, 2020–2025
           TABLE 183 MARKET FOR DENTAL APPLICATIONS, BY REGION, 2016–2019
           TABLE 184 MARKET FOR DENTAL APPLICATIONS, BY REGION, 2020–2025
           8.5.1 DENTAL IMPLANTS
                    8.5.1.1 Increasing awareness of dental services and improving quality of dental products are driving the growth of this market segment
                               TABLE 185 PERCENTAGE OF INDIVIDUALS WITH UNTREATED DENTAL CARIES IN THE US (2016)
                               TABLE 186 GLOBAL MARKET FOR DENTAL IMPLANTS, BY REGION, 2016–2019
                               TABLE 187 MARKET FOR DENTAL IMPLANTS, BY REGION, 2020–2025
           8.5.2 DENTAL BONE GRAFTS & SUBSTITUTES
                    8.5.2.1 Growing demand for dental implants among people opting for cosmetic dentistry to drive market growth
                               TABLE 188 MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES, BY REGION, 2016–2019
                               TABLE 189 GLOBAL MARKET FOR DENTAL BONE GRAFTS & SUBSTITUTES, BY REGION, 2020–2025
           8.5.3 DENTAL MEMBRANES
                    8.5.3.1 Dental membranes are widely used in oral and periodontal surgery to prevent unwanted infections in the oral cavity
                               TABLE 190 GLOBAL MARKET FOR DENTAL MEMBRANES, BY REGION, 2016–2019
                               TABLE 191 MARKET FOR DENTAL MEMBRANES, BY REGION, 2020–2025
           8.5.4 TISSUE REGENERATION MATERIALS
                    8.5.4.1 Increasing prevalence of periodontal disease is driving the market for biomaterials in this particular application
                               TABLE 192 MARKET FOR TISSUE REGENERATION, BY REGION, 2016–2019
                               TABLE 193 GLOBAL MARKET FOR TISSUE REGENERATION, BY REGION, 2020–2025
    8.6 PLASTIC SURGERY
           TABLE 194 BIOMATERIALS MARKET FOR PLASTIC SURGERY, BY APPLICATION, 2016–2019
           TABLE 195 MARKET FOR PLASTIC SURGERY, BY APPLICATION, 2020–2025
           TABLE 196 MARKET FOR PLASTIC SURGERY, BY REGION, 2016–2019
           TABLE 197 GLOBAL MARKET FOR PLASTIC SURGERY, BY REGION, 2020–2025
           8.6.1 SOFT-TISSUE FILLERS
                    8.6.1.1 Advantages such as long-lasting capacity and less allergic reactions to drive the demand for soft-tissue fillers
                               TABLE 198 GLOBAL MARKET FOR SOFT-TISSUE FILLERS, BY REGION, 2016–2019
                               TABLE 199 MARKET FOR SOFT-TISSUE FILLERS, BY REGION, 2020–2025
           8.6.2 CRANIOFACIAL SURGERY
                    8.6.2.1 Increasing incidence of trauma cases and head & neck cancer to increase the number of craniofacial surgeries
                               TABLE 200 MARKET FOR CRANIOFACIAL SURGERY, BY REGION, 2016–2019
                               TABLE 201 GLOBAL MARKET FOR CRANIOFACIAL SURGERY, BY REGION, 2020–2025
    8.7 WOUND HEALING
           TABLE 202 GLOBAL MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2016–2019
           TABLE 203 MARKET FOR WOUND HEALING APPLICATIONS, BY PRODUCT, 2020–2025
           TABLE 204 MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2016–2019
           TABLE 205 GLOBAL MARKET FOR WOUND HEALING APPLICATIONS, BY REGION, 2020–2025
           8.7.1 WOUND CLOSURE DEVICES
                    TABLE 206 BIOMATERIALS MARKET FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2016–2019
                    TABLE 207 MARKET FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2020–2025
                    TABLE 208 MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2016–2019
                    TABLE 209 GLOBAL MARKET FOR WOUND CLOSURE DEVICES, BY REGION, 2020–2025
                    8.7.1.1 Sutures
                               8.7.1.1.1 Sutures can be used as advanced biologically active components enabling the delivery of drugs
                                             TABLE 210 GLOBAL MARKET FOR SUTURES, BY REGION, 2016–2019
                                             TABLE 211 MARKET FOR SUTURES, BY REGION, 2020–2025
                    8.7.1.2 Staples
                               8.7.1.2.1 Staples are easy to place and can shorten the closure by 70–80% compared to sutures
                                             TABLE 212 MARKET FOR STAPLES, BY REGION, 2016–2019
                                             TABLE 213 GLOBAL MARKET FOR STAPLES, BY REGION, 2020–2025
           8.7.2 SURGICAL HEMOSTATS
                    8.7.2.1 Surgical hemostats have the ability to control bleeding and reduce the need for frequent blood transfusions during surgical procedures
                               TABLE 214 MARKET FOR SURGICAL HEMOSTATS, BY REGION, 2016–2019
                               TABLE 215 GLOBAL MARKET FOR SURGICAL HEMOSTATS, BY REGION, 2020–2025
           8.7.3 INTERNAL TISSUE SEALANTS
                    8.7.3.1 Internal tissue sealants are made of biomaterials such as fibrin, gelatin, thrombin, synthetic polymers, and biosynthetic polymers
                               TABLE 216 MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2016–2019
                               TABLE 217 GLOBAL MARKET FOR INTERNAL TISSUE SEALANTS, BY REGION, 2020–2025
           8.7.4 ADHESION BARRIERS
                    8.7.4.1 Biomaterials such as Teflon sheets, animal membranes, gold foil, silk, and rubber are used as adhesion barriers
                               TABLE 218 MARKET FOR ADHESION BARRIERS, BY REGION, 2016–2019
                               TABLE 219 BIOMATERIALS MARKET FOR ADHESION BARRIERS, BY REGION, 2020–2025
           8.7.5 HERNIA MESHES
                    8.7.5.1 Meshes used in hernia repair are mainly made up of polymeric biomaterials
                               TABLE 220 GLOBAL MARKET FOR HERNIA MESHES, BY REGION, 2016–2019
                               TABLE 221 MARKET FOR HERNIA MESHES, BY REGION, 2020–2025
    8.8 TISSUE ENGINEERING
           TABLE 222 TISSUE ENGINEERING MARKET, BY APPLICATION, 2016–2019
           TABLE 223 TISSUE ENGINEERING MARKET, BY APPLICATION, 2020–2025
           TABLE 224 TISSUE ENGINEERING MARKET, BY REGION, 2016–2019
           TABLE 225 TISSUE ENGINEERING MARKET, BY REGION, 2020–2025
           8.8.1 SCAFFOLDS FOR REGENERATIVE MEDICINE
                    8.8.1.1 Rise in organ transplantation procedures to drive the market
                               TABLE 226 TISSUE ENGINEERING MARKET FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2016–2019
                               TABLE 227 TISSUE ENGINEERING MARKET FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2020–2025
           8.8.2 NANOMATERIALS FOR BIOSENSING
                    8.8.2.1 Growth in this segment will be driven by rising research in the field of nanotechnology
                               TABLE 228 TISSUE ENGINEERING MARKET FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2016–2019
                               TABLE 229 TISSUE ENGINEERING MARKET FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2020–2025
           8.8.3 TAILORING OF INORGANIC NANOPARTICLES
                    8.8.3.1 Growing demand for nanotechnological medical products will be a key factor in driving the growth of this market
                               TABLE 230 TISSUE ENGINEERING MARKET FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2016–2019
                               TABLE 231 TISSUE ENGINEERING BIOMATERIALS MARKET FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2020–2025
    8.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM APPLICATIONS
           TABLE 232 BIOMATERIALS MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY PRODUCT, 2016–2019
           TABLE 233 MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY PRODUCT, 2020–2025
           TABLE 234 GLOBAL MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY REGION, 2016–2019
           TABLE 235 MARKET FOR NEUROLOGICAL/CNS APPLICATIONS, BY REGION, 2020–2025
           8.9.1 SHUNTING SYSTEMS
                    8.9.1.1 Rising cases of hydrocephalus will boost the market growth
                               TABLE 236 GLOBAL MARKET FOR SHUNTING SYSTEMS, BY REGION, 2016–2019
                               TABLE 237 MARKET FOR SHUNTING SYSTEMS, BY REGION, 2020–2025
           8.9.2 CORTICAL NEURAL PROSTHETICS
                    8.9.2.1 Polymer-coated CNPs are relatively new in the market and are mainly used to treat paralyzed patients
                               TABLE 238 GLOBAL MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2016–2019
                               TABLE 239 MARKET FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2020–2025
           8.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR
                    8.9.3.1 With increasing incidence of spinal cord surgeries, the demand for hydrogel scaffolds is expected to grow in the coming years
                               TABLE 240 GLOBAL MARKET FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR, BY REGION, 2016–2019
                               TABLE 241 MARKET FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR, BY REGION, 2020–2025
           8.9.4 NEURAL STEM CELL ENCAPSULATION
                    8.9.4.1 Lack of substitutes for the treatment of neurotrauma is boosting the market growth
                               TABLE 242 BIOMATERIALS MARKET FOR NEURAL STEM CELL ENCAPSULATION, BY REGION, 2016–2019
                               TABLE 243 MARKET FOR NEURAL STEM CELL ENCAPSULATION, BY REGION, 2020–2025
    8.10 OTHER APPLICATIONS
           TABLE 244 OTHER BIOMATERIAL APPLICATIONS MARKET, BY TYPE, 2016–2019
           TABLE 245 OTHER BIOMATERIAL APPLICATIONS MARKET, BY TYPE, 2020–2025
           TABLE 246 OTHER BIOMATERIAL APPLICATIONS MARKET, BY REGION, 2016–2019
           TABLE 247 OTHER BIOMATERIAL APPLICATIONS MARKET, BY REGION, 2020–2025
           8.10.1 DRUG DELIVERY SYSTEMS
                    TABLE 248 GLOBAL MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION, 2016–2019
                    TABLE 249 MARKET FOR DRUG DELIVERY SYSTEMS, BY REGION, 2020–2025
           8.10.2 GASTROINTESTINAL APPLICATIONS
                    TABLE 250 GLOBAL MARKET FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2016–2019
                    TABLE 251 MARKET FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2020–2025
           8.10.3 BARIATRIC SURGERY
                    TABLE 252 GLOBAL MARKET FOR BARIATRIC SURGERY, BY REGION, 2016–2019
                    TABLE 253 MARKET FOR BARIATRIC SURGERY, BY REGION, 2020–2025
           8.10.4 URINARY APPLICATIONS
                    TABLE 254 GLOBAL MARKET FOR URINARY APPLICATIONS, BY REGION, 2016–2019
                    TABLE 255 MARKET FOR URINARY APPLICATIONS, BY REGION, 2020–2025

9 BIOMATERIALS MARKET, BY REGION (Page No. - 204)
    9.1 INTRODUCTION
           TABLE 256 BIOMATERIALS MARKET, BY REGION, 2016–2019
           TABLE 257 MARKET, BY REGION, 2020–2025
           FIGURE 33 MARKET, BY REGION, 2020 VS. 2025
    9.2 NORTH AMERICA
           FIGURE 34 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT
           TABLE 258 NORTH AMERICA: MARKET, BY COUNTRY, 2016–2019
           TABLE 259 NORTH AMERICA: MARKET, BY COUNTRY, 2020–2025
           TABLE 260 NORTH AMERICA: MARKET, BY TYPE, 2016–2019
           TABLE 261 NORTH AMERICA: MARKET, BY TYPE, 2020–2025
           TABLE 262 NORTH AMERICA: MARKET, BY APPLICATION, 2016–2019
           TABLE 263 NORTH AMERICA: MARKET, BY APPLICATION, 2020–2025
           9.2.1 US
                    9.2.1.1 US dominates the North American biomaterials market
                               TABLE 264 US: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                               TABLE 265 US: MARKET, BY TYPE, 2020–2025
                               TABLE 266 US: MARKET, BY APPLICATION, 2016–2019
                               TABLE 267 US: MARKET, BY APPLICATION, 2020–2025
           9.2.2 CANADA
                    9.2.2.1 Increasing incidence of cardiovascular diseases to drive market growth in Canada
                               TABLE 268 CANADA: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                               TABLE 269 CANADA: MARKET, BY TYPE, 2020–2025
                               TABLE 270 CANADA: MARKET, BY APPLICATION, 2016–2019
                               TABLE 271 CANADA: MARKET, BY APPLICATION, 2020–2025
    9.3 EUROPE
           TABLE 272 EUROPE: BIOMATERIALS MARKET, BY COUNTRY, 2016–2019
           TABLE 273 EUROPE: MARKET, BY COUNTRY, 2020–2025
           TABLE 274 EUROPE: MARKET, BY TYPE, 2016–2019
           TABLE 275 EUROPE: MARKET, BY TYPE, 2020–2025
           TABLE 276 EUROPE: MARKET, BY APPLICATION, 2016–2019
           TABLE 277 EUROPE: MARKET, BY APPLICATION, 2020–2025
           9.3.1 GERMANY
                    9.3.1.1 Large medical device market to support the adoption of biomaterials in Germany
                               TABLE 278 GERMANY: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                               TABLE 279 GERMANY: MARKET, BY TYPE, 2020–2025
                               TABLE 280 GERMANY: MARKET, BY APPLICATION, 2016–2019
                               TABLE 281 GERMANY: MARKET, BY APPLICATION, 2020–2025
           9.3.2 UK
                    9.3.2.1 Availability of funds and the increasing number of cardiovascular procedures to drive the biomaterials market in the UK
                               TABLE 282 UK: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                               TABLE 283 UK: MARKET, BY TYPE, 2020–2025
                               TABLE 284 UK: MARKET, BY APPLICATION, 2016–2019
                               TABLE 285 UK: MARKET, BY APPLICATION, 2020–2025
           9.3.3 FRANCE
                    9.3.3.1 Rising aging population and associated diseases to drive the market in France
                               TABLE 286 FRANCE: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                               TABLE 287 FRANCE: MARKET, BY TYPE, 2020–2025
                               TABLE 288 FRANCE: MARKET, BY APPLICATION, 2016–2019
                               TABLE 289 FRANCE: MARKET, BY APPLICATION, 2020–2025
           9.3.4 SPAIN
                    9.3.4.1 Increasing research activities on biomaterials to drive growth in Spain
                               TABLE 290 SPAIN: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                               TABLE 291 SPAIN: MARKET, BY TYPE, 2020–2025
                               TABLE 292 SPAIN: MARKET, BY APPLICATION, 2016–2019
                               TABLE 293 SPAIN: MARKET, BY APPLICATION, 2020–2025
           9.3.5 REST OF EUROPE (ROE)
                    TABLE 294 ROE: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                    TABLE 295 ROE: MARKET, BY TYPE, 2020–2025
                    TABLE 296 ROE: MARKET, BY APPLICATION, 2016–2019
                    TABLE 297 ROE: MARKET, BY APPLICATION, 2020–2025
    9.4 ASIA PACIFIC
           FIGURE 35 ASIA PACIFIC: BIOMATERIALS MARKET SNAPSHOT
           TABLE 298 APAC: MARKET, BY COUNTRY, 2016–2019
           TABLE 299 APAC: MARKET, BY COUNTRY, 2020–2025
           TABLE 300 APAC: MARKET, BY TYPE, 2016–2019
           TABLE 301 APAC: MARKET, BY TYPE, 2020–2025
           TABLE 302 APAC: MARKET, BY APPLICATION, 2016–2019
           TABLE 303 APAC: MARKET, BY APPLICATION, 2020–2025
           9.4.1 JAPAN
                    9.4.1.1 Growing medical devices industry to drive market growth
                               TABLE 304 JAPAN: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                               TABLE 305 JAPAN: MARKET, BY TYPE, 2020–2025
                               TABLE 306 JAPAN: MARKET, BY APPLICATION, 2016–2019
                               TABLE 307 JAPAN: MARKET, BY APPLICATION, 2020–2025
           9.4.2 CHINA
                    9.4.2.1 Lucrative medical devices industry in China to drive market growth
                               TABLE 308 CHINA: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                               TABLE 309 CHINA: MARKET, BY TYPE, 2020–2025
                               TABLE 310 CHINA: MARKET, BY APPLICATION, 2016–2019
                               TABLE 311 CHINA: MARKET, BY APPLICATION, 2020–2025
           9.4.3 INDIA
                    9.4.3.1 Large population base and growing medical tourism in India to drive the growth of the biomaterials market
                               TABLE 312 INDIA: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                               TABLE 313 INDIA: MARKET, BY TYPE, 2020–2025
                               TABLE 314 INDIA: MARKET, BY APPLICATION, 2016–2019
                               TABLE 315 INDIA: MARKET, BY APPLICATION, 2020–2025
           9.4.4 REST OF ASIA PACIFIC (ROAPAC)
                    TABLE 316 ROAPAC: BIOMATERIALS MARKET, BY TYPE, 2016–2019
                    TABLE 317 ROAPAC: MARKET, BY TYPE, 2020–2025
                    TABLE 318 ROAPAC: MARKET, BY APPLICATION, 2016–2019
                    TABLE 319 ROAPAC: MARKET, BY APPLICATION, 2020–2025
    9.5 REST OF THE WORLD (ROW)
           TABLE 320 ROW: BIOMATERIALS MARKET, BY TYPE, 2016–2019
           TABLE 321 ROW: MARKET, BY TYPE, 2020–2025
           TABLE 322 ROW: MARKET, BY APPLICATION, 2016–2019
           TABLE 323 ROW: MARKET, BY APPLICATION, 2020–2025

10 COMPETITIVE LANDSCAPE (Page No. - 240)
     10.1 OVERVIEW
     10.2 MARKET RANKING ANALYSIS
               FIGURE 36 COMPANY RANKING IN THE BIOMATERIALS MARKET, 2019
     10.3 MARKET EVALUATION FRAMEWORK
               TABLE 324 MARKET EVALUATION FRAMEWORK: PRODUCT LAUNCHES & EXPANSIONS—THE MAJOR STRATEGIES ADOPTED BY PLAYERS
     10.4 COMPETITIVE SCENARIO
             10.4.1 KEY PRODUCT LAUNCHES
             10.4.2 KEY COLLABORATIONS, PARTNERSHIPS, AND AGREEMENTS
             10.4.3 KEY ACQUISITIONS
             10.4.4 KEY EXPANSIONS

11 COMPANY EVALUATION MATRIX AND COMPANY PROFILES (Page No. - 244)
     11.1 OVERVIEW
     11.2 GLOBAL BIOMATERIALS MARKET: COMPANY EVALUATION MATRIX
             11.2.1 STARS
             11.2.2 EMERGING LEADERS
             11.2.3 PERVASIVE PLAYERS
             11.2.4 PARTICIPANTS
                       FIGURE 37 GLOBAL MARKET: COMPANY EVALUATION MATRIX, 2019
     11.3 COMPANY PROFILES
(Business overview, Products offered, Recent developments & MnM View)*
             11.3.1 BASF SE
                       FIGURE 38 BASF: COMPANY SNAPSHOT
             11.3.2 COVESTRO AG
                       FIGURE 39 COVESTRO: COMPANY SNAPSHOT
             11.3.3 CELANESE CORPORATION
                       FIGURE 40 CELANESE CORPORATION: COMPANY SNAPSHOT
             11.3.4 CARPENTER TECHNOLOGY CORPORATION
                       FIGURE 41 CARPENTER TECHNOLOGY CORPORATION: COMPANY SNAPSHOT
             11.3.5 ROYAL DSM
                       FIGURE 42 ROYAL DSM: COMPANY SNAPSHOT
             11.3.6 CORBION
                       FIGURE 43 CORBION: COMPANY SNAPSHOT
             11.3.7 EVONIK INDUSTRIES
                       FIGURE 44 EVONIK INDUSTRIES: COMPANY SNAPSHOT
             11.3.8 VICTREX PLC
                       FIGURE 45 VICTREX PLC: COMPANY SNAPSHOT
             11.3.9 CERAMTEC GMBH
                       FIGURE 46 CERAMTEC GMBH: COMPANY SNAPSHOT
               11.3.10 MITSUBISHI CHEMICAL HOLDINGS CORPORATION (ADVANSOURCE BIOMATERIALS CORP.)
                       FIGURE 47 MITSUBISHI CHEMICAL HOLDINGS CORPORATION: COMPANY SNAPSHOT
               11.3.11 COORSTEK INC.
               11.3.12 BERKELEY ADVANCED BIOMATERIALS
               11.3.13 CAM BIOCERAMICS B.V.
               11.3.14 ZEUS INDUSTRIAL PRODUCTS, INC.
               11.3.15 GELITA AG
               11.3.16 RDI GROUP (COLLAGEN SOLUTIONS PLC)
               11.3.17 RITON BIOMATERIAL CO., LTD.
               11.3.18 ARTOSS, INC.
               11.3.19 NOBEL BIOMATERIALS
               11.3.20 DIMENSION INX

*Details on Business overview, Products offered, Recent developments & MnM View might not be captured in case of unlisted companies.

12 ADJACENT/RELATED MARKETS (Page No. - 277)
     12.1 INTRODUCTION
     12.2 LIMITATIONS
     12.3 MEDICAL CERAMICS MARKET
             12.3.1 MARKET DEFINITION
             12.3.2 MARKET OVERVIEW
             12.3.3 MEDICAL CERAMICS MARKET, BY REGION
                       TABLE 325 MEDICAL CERAMICS MARKET, BY REGION, 2018–2025
                       12.3.3.1 North America
                                   TABLE 326 NORTH AMERICA: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025
                       12.3.3.2 Europe
                                   TABLE 327 EUROPE: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025
                       12.3.3.3 Asia Pacific
                                   TABLE 328 ASIA PACIFIC: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025
                       12.3.3.4 Latin America
                                   TABLE 329 LATIN AMERICA: MEDICAL CERAMICS MARKET, BY COUNTRY, 2018–2025
     12.4 BONE CEMENT & GLUE MARKET
             12.4.1 MARKET DEFINITION
             12.4.2 MARKET OVERVIEW
             12.4.3 BONE CEMENT & GLUE MARKET, BY REGION
                       TABLE 330 BONE CEMENT & GLUE MARKET, BY REGION, 2015–2022
                       12.4.3.1 North America
                                   TABLE 331 NORTH AMERICA: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2015–2022
                       12.4.3.2 Europe
                                   TABLE 332 EUROPE: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2015–2022
                       12.4.3.3 Asia Pacific
                                   TABLE 333 ASIA PACIFIC: BONE CEMENT & GLUE MARKET, BY COUNTRY, 2015–2022

13 APPENDIX (Page No. - 283)
     13.1 DISCUSSION GUIDE
     13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
     13.3 AVAILABLE CUSTOMIZATIONS
     13.4 RELATED REPORTS
     13.5 AUTHOR DETAILS

This study involved four major activities in estimating the current size of the biomaterials market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of segments and subsegments.

Secondary Research

Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the biomaterials market. The secondary sources used for this study include Some of the key secondary sources referred to for this study include Centre for Advanced Materials and Biomaterials Research (CAMBR), Institute of Biomaterial Science, Medical Design Technology Magazine, Centre for Biomedical and Biomaterials Research (CBBR), Institute of Biomaterials, Biomedical Engineering, and Biomaterials Research Center. These sources were also used to obtain key information about major players, market classification, and segmentation according to industry trends, regional/country-level markets, market developments, and technology perspectives.

Primary Research

In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among other experts, to obtain and verify the critical qualitative and quantitative information as well as assess future prospects of the market. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:

Biomaterials Market Size

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the biomaterials market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and market have been identified through extensive secondary research
  • The revenues generated from the biomaterials business of leading players have been determined through primary and secondary research
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

Report Objectives

  • To define, describe, and forecast the global biomaterials market based on the type, application and region
  • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, challenges, opportunities and trends)
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall biomaterials market
  • To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, Asia Pacific, and Rest of the World
  • To strategically profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
  • To track and analyze competitive developments such as acquisitions, product launches, expansions, agreements, partnerships, and R&D activities in the biomaterials market.

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for this report:

Company Information

  • An additional five company profiles
Report Code
BT 1556
Published ON
Jan, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Biomaterials Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2023 MarketsandMarkets Research Private Ltd. All rights reserved
DMCA.com Protection Status Website Feedback